by Hamideh Emrani | Nov 4, 2015
Among many interesting talks at this year’s Till and McCulloch Meetings in Toronto, Canada, there were a couple related to biomaterials, which I’d like to focus on. In the first talk, professor Milica Radisic, University of Toronto, talked about two recent...
by Nicole Kuchinsky | Nov 3, 2015
At one point or another we’ve all experienced a bad haircut. We get over such minor annoyances secure in the knowledge that “it will grow back.” The ability of our hair to grow back is based on the amazing capacity of the hair follicle to undergo continuous cycles of...
by Mark Curtis | Oct 27, 2015
Welcome to your Update from the Clinic for the month of September. OncoSec Medical released some initial data from its Phase 1/2 study investigating ImmunoPulse IL-12 DNA in a rare skin cancer. Pluristem and the National Institute of Allergy and Infectious Diseases...
by Hamideh Emrani | Oct 21, 2015
Another in the series: “What Drives Research in the Field of Biomaterials?” The amazingly complex system of the brain, and its network of many different cell types interacting and functioning together, has always been “top of mind” – pardon the pun – for many...
by Mark Curtis | Oct 20, 2015
. Welcome to your Cell Therapy Deal Review for the month of September. Aduro Biotech went the way of Juno and Kite and bought an antibody discovery platform. Intrexon and ZIOPHARM entered into an agreement to develop a novel Treg-based immunotherapy for GvHD. Kite...
by Nicole Kuchinsky | Oct 15, 2015
Last week, a Nature News article reported that the Harvard geneticist George Church had modified over 60 genes in pig embryos using CRISPR/Cas9 gene editing. I’m sure you’re expecting my scientific perspective on the significance of this news in the context of the...
Comments